Interim guidance for a public health response to contain novel or targeted multidrug-resistant organisms (MDROs)

Details

• Corporate Authors:
  National Center for Emerging and Zoonotic Infectious Diseases (U.S.)
• Description:
  Updated December 2022
  
  This document is intended for use by state, local, territorial, and tribal health departments and healthcare facilities. It was developed with input from state and local health departments and serves as general guidance for the initial response following the identification of novel or targeted multidrug-resistant organisms (MDROs) or resistance mechanisms. Response recommendations are for MDROs that are in pre-endemic stages of spread, for which a public health response to identified cases is an important strategy to limit transmission. Recommendations are not inclusive of all the actions that might be required for control of an outbreak (e.g., sustained transmission within a facility or region).
  
  Please refer to the complementary document, Public Health Strategies to Prevent the Spread of Novel and Targeted Multidrug-resistant Organisms (MDROs), for information about the development, implementation, and coordination of activities designed to prevent transmission of targeted MDROs at all epidemiologic stages (from pre-introduction through endemicity) across healthcare facilities within a jurisdiction. Combining prevention and response strategies has the potential to be more effective than either strategy alone.
  
  326227-A
  
  Health-Response-Contain-MDRO-H.pdf
  
  
• Subjects:
  Anti-Bacterial Agents/pharmacology Cross Infection Drug Resistance, Multiple, Bacterial Hospitals Infection Control
• Document Type:
  Pamphlet (or booklet)
• Pages in Document:
  24 numbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:4d556d0a5d3ccfca795f972c50dc2b3cc3a3b040d0fafbc804d6423fc2151ea6
• Download URL:
  https://stacks.cdc.gov/view/cdc/137366/cdc_137366_DS1.pdf
• File Type:
  [PDF - 517.20 KB ]